Phase 2 clinical trial underway with first patient dosed in October to support a clear path to Phase 3 based on previous alignment with FDA Patients randomized to either 10 or 20 mg/kg of muzastotug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback